Exponent, Inc. (EXPO)

Nasdaq Industrials Research & Consulting Services S&P MidCap 400
$84.02
-1.81 (-2.11%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+4.7%
1M+20.4%
3M+24.4%
6M+36.8%
YTD+21.0%
1Y+14.1%
3Y+18.8%
5Y-26.8%

Key statistics

Full financials →
Market cap$4.0B
P/E (TTM)36.2
EPS (TTM, diluted)$2.32
P/S6.06
P/B12.98
EV / EBITDA25.7
Revenue (TTM)$659.00M
Revenue growth+15.4%
Net margin17.4%
ROE37.2%
Debt / equity0.00
FCF yield3.5%
Dividend yield1.46%
Payout ratio53%
Beta (1Y)0.35
Volatility (1Y)33.1%
52-week range$51.91 – $90.51
Avg volume (50D)560.70K

Revenue & net income — last 8 quarters

Statements →
Oct 29, 4:05 PM ET

Exponent Q3 revenue rises 18% to $173.7 million; raises full-year guidance

Positive guidance 2.027.01

Exponent reported third-quarter 2026 total revenues up 18% to $173.7 million and net income of $30.9 million, or $0.64 per diluted share, compared with $0.55 a year earlier. The company raised its full-year 2026 revenue and margin guidance and declared a $0.31 quarterly dividend payable December 18, 2026.

  • Revenues before reimbursements rose 12% to $153.1 million; EBITDA was $45.0 million, or 29.4% of those revenues.
  • Full-year 2026 outlook: revenues before reimbursements to grow 10% to 11%, and EBITDA to be 28.0% to 28.3% of revenues before reimbursements.
  • Fourth-quarter 2026 outlook: revenues before reimbursements to grow 8% to 10%, and EBITDA to be 26.3% to 26.8% of revenues before reimbursements.
  • Quarterly cash dividend of $0.31 per share, with a record date of December 4, 2026 and payment on December 18, 2026.
Read the filing on SEC.gov ↗
Jul 30, 4:05 PM ET

Exponent Q2 revenue rises 21% to $171.6 million; full-year revenue guidance raised

Positive earnings Written later 2.027.01

Exponent reported second-quarter 2026 results for the quarter ended July 3, 2026, with total revenues up 21% to $171.6 million and net income up to $29.4 million, or $0.60 per diluted share, from $0.52 a year earlier. The company raised its full-year 2026 revenue growth and EBITDA margin guidance and declared a $0.31 quarterly dividend and an additional $50 million share repurchase authorization.

  • Q2 revenues before reimbursements rose 12% to $148.9 million; net income was $29.4 million, or $0.60 per diluted share, versus $26.6 million, or $0.52, in Q2 2025.
  • Full-year 2026 guidance raised: revenues before reimbursements to grow 9% to 10%, and EBITDA to be 27.8% to 28.1% of revenues before reimbursements.
  • Third-quarter 2026 outlook: revenues before reimbursements expected to grow 8% to 10%, with EBITDA at 28.0% to 28.5% of revenues before reimbursements.
  • Quarterly dividend of $0.31 per share is payable September 18, 2026, to holders of record as of September 4, 2026; the buyback authorization was increased by $50 million.
Read the filing on SEC.gov ↗
Apr 30, 4:05 PM ET

Exponent Q1 2026 revenue rises 14% to $166.3 million; profit up, $50 million buyback added

Positive earnings Written later 2.027.01

Exponent reported first-quarter fiscal 2026 results with total revenues up 14% to $166.3 million and net income up to $29.6 million, or $0.59 per diluted share, from $0.52 a year earlier. The company maintained its full-year 2026 guidance and set a quarterly dividend of $0.31 per share, while its Board added $50 million to the share repurchase authorization.

  • Revenues before reimbursements rose 10% to $151.8 million; total revenues rose 14% to $166.3 million.
  • Net income was $29.6 million, or $0.59 per diluted share, versus $26.7 million, or $0.52, a year earlier.
  • EBITDA rose to $43.1 million, or 28.4% of net revenues, from $37.5 million, or 27.3%.
  • Dividend of $0.31 per share is payable June 18, 2026 to holders of record as of June 5, 2026; $17.7 million remained for repurchases as of April 3, 2026, before the $50 million increase.
Read the filing on SEC.gov ↗
Apr 6, 4:35 PM ET

Exponent names John Pye President and Eric Anderson CFO, effective May 1, 2026

Neutral leadership Written later 5.02

Exponent, Inc. (EXPO) said its board appointed John Pye, Ph.D., as President and Eric Anderson as Chief Financial Officer, both effective May 1, 2026, and both will report to CEO Catherine Corrigan. Current CFO Richard Schlenker will remain Executive Vice President and has been nominated for election to the board, while director Paul Johnston retires and Karen Richardson becomes Chairman at the June 4, 2026 annual meeting.

  • John Pye, who joined the company in 1999 and is currently Vice President of Global Offices and Innovation, becomes President effective May 1, 2026, with a base salary of $650,000 and a stock option grant covering 21,000 shares.
  • Eric Anderson, Vice President of Finance and Accounting since 2024 and a company employee since 2003, becomes Chief Financial Officer effective May 1, 2026, with a base salary of $525,000 and a stock option grant covering 12,600 shares.
  • Richard Schlenker stops being Chief Financial Officer on May 1, 2026, stays on as Executive Vice President, and has been nominated to stand for election to the board.
  • Paul Johnston retires from the board at the Annual Meeting of Stockholders on June 4, 2026, and Karen Richardson, the Lead Independent Director, will then become Chairman.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own EXPO

All investors →
InvestorValue% of portfolioLast quarter
Ray Dalio Bridgewater Associates $441.11K0.00% New

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All EXPO congressional trades →
TradedMemberTypeAmount
Sep 11, 2025Lisa McClain MI-09 · SpouseSell$1,001 – $15,000
Aug 13, 2025Lisa McClain MI-09 · SpouseBuy$1,001 – $15,000
May 12, 2025Jefferson Shreve IN-06Sell$15,001 – $50,000
Feb 24, 2025Jefferson Shreve IN-06Buy$15,001 – $50,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
Nov 03Reiss Richard
Group Vice President
Sell1.28K$86.44$110.64K

Prices are end-of-day and split-adjusted. Financial data from Exponent, Inc.'s SEC XBRL filings. Not investment advice.